Details for Patent: 7,465,462

Summary for Patent: 7,465,462

Title:	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
Abstract:	A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a pharmaceutically acceptable salt thereof, which are coated with a rate-controlling polymer that allows controlled release of the SSRI over a period of not less than about 12 hours after oral administration. The rate controlling polymer includes a film-forming water-insoluble polymer, or a mixture of a film-forming water-insoluble polymer and a film-forming water-soluble polymer.
Inventor(s):	Jeary; Theresa Ann (Roscommon, IE), Morrissey; Catherine Ann (County Westmeath, IE), Stark; Paul (County Westmeath, IE)
Assignee:	Elan Pharma International Limited (Monksland Athlone County Westmeath, IL)
Application Number:	09/744,169
Patent Claim Types: see list of patent claims	Composition; Formulation; Dosage form; Device; Use;

Drugs Protected by US Patent 7,465,462

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 7,465,462

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Ireland	990406	May 20, 1999

PCT Information
PCT Filed	May 10, 2000	PCT Application Number:	PCT/IE00/00060
PCT Publication Date:	November 30, 2000	PCT Publication Number:	WO00/71099

International Family Members for US Patent 7,465,462

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	367153
Australia	4426700
Australia	782059
Canada	2374039
Canada	2698347
Cyprus	1107750